2025 INOVIO Stock Forecast: Will It Reach $20?
The future of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) stock is a topic of great interest to investors. The company is a clinical-stage biopharmaceutical company developing DNA-based immunotherapies for the treatment of cancer and infectious diseases. Inovio’s lead product candidate is VGX-3100, a DNA-based immunotherapy for the treatment of cervical cancer. The company also has a … Read more
